Aventis Pharma Deutschland, Gmbh

Sanofi-a Ventis Deutschland Gmbh

Hoechst Marion Roussel Deutschland Gmbh

Matthias Schiell

Laszlo Vertesy

Michael Kurz

Herbert Kogler

Joachim Hofmann

Joachim Wink

Astrid Markus

Luigi Toti

Martin Knauf

Sabine Haag-Richter

Astrid Markus-Erb

L&aacute;szl&oacute; V&eacute;rtesy

The invention relates to compounds of the formula IAcPhe-Aib-Aib-Aib-x-w-Leu-y-Aib-Hyp-Gln-z-Hyp-Aib-Pro-R &#x2003;&#x2003;(I)in which R is Phe-ol or Phe-al and w, x, y, and z have the following meanings:

[object Object]

The present invention relates to compounds of the formula (I)which are formed by the microorganism ST 003236 (DSM 14476) during fermentation, to a process for preparing and derivatizing them, to a pharmaceutical which comprises a compound of the formula (I) and to the use thereof for producing a pharmaceutical.

Gabusectin derivatives, processes for preparing them and their use

The present invention relates to compounds of the formula (I):which are produced by the plant, chemical derivatives derived therefrom, a process for their preparation, and their use as pharmaceuticals, in particular for the treatment and/or prophylaxis of bacterial infectious diseases.

Polyisoprenylbenzophenone derivatives, processes for their preparation and use thereof

Memno peptides, process for their preparation and use thereof

Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof

The present invention relates to a novel lantibiotic having the formula NH.sub.2 --R-actagardine, where NH.sub.2 --R is the radical of the amino acid alanine, which is formed by the microorganism Actinoplanes liguriae, DSM 11797 or Actinoplanes garbadiensis, DSM 11796 during fermentation, chemical derivatives of the lantibiotic, a process for its preparation and the use of the lantibiotics as pharmaceuticals.

Lantibiotic related to actagardine, and processes for the preparation

Growing community of inventors

Brechen, Germany

Matthias Schiell